期刊文献+

非酒精性脂肪性肝炎的临床病理研究 被引量:2

CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF NONALCOHOLIC STEATOHEPATITIS
下载PDF
导出
摘要 探讨非酒精性脂肪性肝炎 (NASH)的临床和病理学特征。对 4 0例NASH患者的临床资料和穿刺肝组织进行临床和病理学分析 ,并与酒精性脂肪性肝炎 (ASH)和丙型肝炎 (HCV)患者各 2 0例作对照。 90 %NASH患者肥胖 ,血浆总蛋白平均水平高于ASH。NASH的组织学改变类似ASH ,但有些组织学改变如脂肪变性、汇管区的炎症程度 ,Mallory小体和空泡状核的出现频率等两者间差异有显著性意义。NASH有其相对的病理特征 :大小泡混合型脂肪变性 ,以大泡为主 ;肝细胞气球样变性 ,小叶中央区较常见 ,气球样变性的细胞胞浆内常有嗜碱性的细颗粒 ;肝小叶内炎症 ,不典型的Mallory小体 ,汇管区周围易见空泡状核细胞。多数NASH患者的肝小叶中央区有不同程度的窦周纤维化。NASH有一些相对的临床和病理学特征 ,临床、病理及实验室检查相结合能对NASH作出肯定的诊断 ,其中病理活检仍然是诊断NASH的“金标准”。 To explore the clinical and pathological characteristics of non alcoholic steatohepatitis(NASH), clinical, laboratory records and liver biopsy specimens of 40 cases of NASH, 20 cases of alcoholic steatohepatitis(ASH) and 20 cases of HCV were compared. The frequency of obesity was significtantly greater in NASH than in ASH patients, while the mean level of total serum protein was higher in patients with NASH than that in those with ASH. The histopathologic lesions in NASH were similar but not identical to those of ASH. Significant differences were found in the grade of steatosis, portal inflammation, Mallory bodies and nuclear vacuolation. The lesions most commonly accepted for NASH include steatosis(macro>micro), hepatocyte ballooning degeneration, mild diffuse lobular inflammation and perisinusoidal collagen deposition. Zone 3 accentuation could be detected. Mallory hyaline, vacuolated nuclei in periportal hepatocytes were common. NASH has some clinical and pathological characteristics. The authors hold that combinative consideration of clinics, pathology and laboratory can ensure the diagnosis of NASH, and liver biopsy interpretation continues to be the 'gold standard ' for diagnosis.
机构地区 解放军第
出处 《解放军医学杂志》 CAS CSCD 北大核心 2002年第9期810-812,共3页 Medical Journal of Chinese People's Liberation Army
基金 全军医学科研"九五"计划面上项目资助课题 (编号 98M1 52 )
关键词 非酒精性脂肪性肝炎 病理学 NASH steatohepatitis liver pathology
  • 相关文献

参考文献6

  • 1[1]Brunt EM, Janney G, Di Bisceglie M et al. Nonalcoholic steatohepatitis: a propsal for grading and staging the histological lesions. Am J Gastroenterol ,1999,94(9):2467
  • 2[2]Falck-Ytter Y, Younossi ZM, Marchesini G et al. Clinical features and natural history of nonalcoholic steatohepatitis syndrome. Seminars in liver Disease,2001,21(1):17
  • 3[3]James OF, Day CP. Nonalcoholic steatohepatitis(NASH): a disease of emerging identity and importance. J Hepatology,1998,29:495
  • 4[4]Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999, 94(4): 1018
  • 5[5]Angulo P, Keach J, Batts K et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology.,1999,30:1356
  • 6[6]Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Seminars in liver Disease,2001,21(1):3

同被引文献19

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 2郑瑞丹,陆伦根,孟家榕,黄俊达,饶日春,徐成润,曾民德.非酒精性脂肪性肝病临床和病理学研究[J].中华肝脏病杂志,2006,14(6):449-452. 被引量:26
  • 3郭雁宾.804例病毒性肝炎活检分析[J].天津医药,1988,16(11):666-666.
  • 4Alberti KG,Zimmet P,Shaw J.The metabolic syndrome-a new worldwide definition.Lancet,2005,366:1059-1062.
  • 5Tsang SW,Ng WF,Wu BP,et al.Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.J Gastroenterol Hepatol,2006,21:116-121.
  • 6Matteoni CA,Younossi ZM,Gramlich T,et al.Nonalcoholic fatty liver disease:A spectrum of clinical and pathological severity.Gastroenterology,1999,116:1413-1419.
  • 7Bahrami H,Daryani NE,Mirmomen S,et al.Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.BMC Gastroenterology,2003,3:27.
  • 8Malik A,Cheah PL,Hilmi IN,et al.Non-alcoholic fatty liver disease in Malaysia:a demographic,anthropometric,metabolic and histological study.J Dig Dis,2007,8:58-64.
  • 9Wong VW,Chan HL,Hui AY,et al.Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.Aliment Pharmacol Ther,2004,20:45-49.
  • 10Ratziu V,Giral P,Charlotte F,et al.Liver fibrosis in overweight patients.Gastroenterology,2000,118:1117-1123.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部